ScholarIQanswers from OpenAlex
PS7:139 Efficacy and safety of rituximab in resistant sle
PaperCitations, authors & open-access status
PS7:139 Efficacy and safety of rituximab in resistant sle is a paper indexed in ScholarIQ from OpenAlex.
How many citations does PS7:139 Efficacy and safety of rituximab in resistant sle have?
ScholarIQcitation count
PS7:139 Efficacy and safety of rituximab in resistant sle has 0 citations in the OpenAlex counts ScholarIQ stores.
When was PS7:139 Efficacy and safety of rituximab in resistant sle published?
ScholarIQyear
PS7:139 Efficacy and safety of rituximab in resistant sle has 2018 year in the ScholarIQ index.
What is the open-access status of PS7:139 Efficacy and safety of rituximab in resistant sle?
ScholarIQoa status
PS7:139 Efficacy and safety of rituximab in resistant sle has gold oa status in the ScholarIQ index.
What is the DOI of PS7:139 Efficacy and safety of rituximab in resistant sle?
ScholarIQdoi
The DOI for PS7:139 Efficacy and safety of rituximab in resistant sle is on the source record.
What is the OpenAlex record for PS7:139 Efficacy and safety of rituximab in resistant sle?
ScholarIQopenalex
The OpenAlex for PS7:139 Efficacy and safety of rituximab in resistant sle is on the source record.